<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The neuronal damage following <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> is a serious risk to <z:hpo ids='HP_0001297'>stroke</z:hpo> patients </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to investigate the neuroprotective effects of <z:chebi fb="13" ids="22315">alkaloid</z:chebi> extract from Leonurus heterophyllus (LHAE) on cerebral ischemic injury </plain></SENT>
<SENT sid="2" pm="."><plain>After 24 h of reperfusion following <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> for 2 h induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO), some rats were intraperitoneally administered different doses of LHAE (3.6, 7.2, 14.4 mg/kg, respectively) </plain></SENT>
<SENT sid="3" pm="."><plain>Neurological examination was measured in <z:hpo ids='HP_0000001'>all</z:hpo> animals </plain></SENT>
<SENT sid="4" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume, myeloperoxidase (MPO) activity, levels of nitrate/<z:chebi fb="95" ids="16301">nitrite</z:chebi> metabolite (NO) and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> ratio of nerve fiber in brain were determined </plain></SENT>
<SENT sid="5" pm="."><plain>The results showed that LHAE at 7.2 mg/kg or 14.4 mg/kg exerted significantly decreasing neurological deficit scores and reducing the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume on rats with focal cerebral ischemic injury (p&lt;0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>At those dose, the MPO content were significantly decreased in ischemic brain as compared with model group (p&lt;0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>LHAE at 14.4 mg/kg significantly decreased the NO level compared with the model group (p&lt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, LHAE significantly decreased the <z:mpath ids='MPATH_3'>apoptosis</z:mpath> ratio of nerve fiber compared with the model group (p&lt;0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>This study suggests that LHAE may be used for treatment of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> as a neuroprotective agent </plain></SENT>
<SENT sid="10" pm="."><plain>Further studies are warranted to assess the efficacy and safety of LHAE in patients </plain></SENT>
</text></document>